Benzinga | Jan 31, 2022 07:30AM EST

EXCLUSIVE: Applied UV Receives Order From Tennessee Department Of Corrections For Its Air S-400 Patented 24/7 Large Air Volume, Whole Room UV-C Pathogen Killing Technology

Mount Vernon, NY // January 31, 2021 -- Applied UV, Inc. (NasdaqCM: AUVI) ("Applied

UV" or the "Company"), a pathogen elimination technology company that applies

the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic

bioconversion technology for air purification to destroy pathogens safely,

thoroughly, and automatically, announces it has received a significant initial order

from the Tennessee Department of Correction ("TDOC") for its Scientific Air S-400

patented 24/7 large air volume, whole room UV-C pathogen killing technology for

use in its Prison and Correctional Facilities protecting incarcerated individuals and

staff from COVID-19 and other pathogens. The Scientific Air technology is currently

deployed and supports patients, staff and visitors in large medical facilities and

hospitals across the country as they address the growing need for effective and safe

airborne Infection prevention. With this order, Applied UV is making its entry into

the prison and correctional facilities vertical, a large and significant new market.

TDOC is a Cabinet-level agency within the Tennessee state government manages

and operates 10 adult prisons, contracts with a private prison management

company for the operation of one prison, and contracts with several counties for the

operation of three other prisons, collectively housing some 21,000 offenders.

Incarcerated people are infected by the coronavirus at a rate more than five

times higher than the nation's overall rate, according to research reported in the

Journal of the American Medical Association in July 2020. The reported death rate of

inmates (39 deaths per 100,000) is also higher than the national rate (29 deaths per

100,000). A significant and increasing percentage of the US population works or

resides in correctional facilities. The prevalence of infectious diseases among

incoming inmates is substantial, and the conditions that exist within jails and

prisons contribute to the further amplification of contagious illnesses. Jails and

prisons represent unique and challenging environments in which to implement

effective infection-control strategies. In addition to immunization programs and

other preventive measures, deploying portable air filter systems like the Scientific

Air S-400 can provide a solution to the unique challenges posed by the spread of

SARS-CoV-2 and other respiratory infections in prison settings and create a cleaner,

safer environment for inmates, staff and visitors.

"We are very pleased to announce this significant initial order from TDOC for the S-

400 ," said Max Munn, Founder, Interim CEO and President of Applied UV. "Our work

with hundreds of large healthcare facilities across the country, where pathogen

spread is an ever-present challenge, has demonstrated the clear and effective

performance of the pathogen destruction capabilities of our air purification

technology. Prisons represent a significant challenge and opportunity, and we

believe our mobile S-400 whole-room disinfection system is the ideal solution for

most correctional facilities. We look forward to installing the systems at TDOC and

vigorously pursuing new opportunities with local, state and federal correctional

facilities to help reduce the spread of SARS-CoV-2 and other respiratory infections."

Scientific Air-S400 Operating Overview

Laboratory validated 99.99%+ kill rate on viruses, bacteria, mold, odors and

VOCS

No harmful by-products

Rapid, portable, whole-room disinfection via patented 3-phase design (HEPA,

UV-C, Carbon)

Safe and fast acting in occupied spaces

Proven and tested in facilities with EPA and FDA guideline compliance and

trusted by Infection Prevention, Facilities, EHS and EVS professionals

Scientific Air Product Portfolio

Developed for healthcare facilities, Scientific Air is helping large facilities and

hospitals across the country address the growing need for effective and safe

airborne Infection prevention. Since 2015 Scientific Air and its predecessors have

been making air safer 24/7 in occupied spaces at facilities like:

NYU Medical Center

University of Rochester Medical Center

The Federal VA Hospital System

Baptist Health South

Kaiser Permanente Medical of California

New York Health + Hospital Corp.

Utilizing Scientific Air systems, large facilities from government to healthcare report

significant reductions in viable airborne pathogens as well as significant declines in

non-viable particulates including elimination of odor and VOC's. To view third-party

disinfection claims of the S400, please click on the following link:

https://scientificairmanagement.com/evidence/

To view a video of our powerful patented UV-C technology and how it disinfects

large volumes of fast-moving air by killing microscopic germs with as much as a

verified 99.9995% efficacy rating, please click on the following link:

https://vimeo.com/521965332. For more information about Scientific Air, please

visit: https://scientificairmanagement.com/

About Applied UV

Applied UV is focused on the development and acquisition of technology that

address infection control in the healthcare, hospitality, commercial and municipal

markets. The Company has two wholly owned subsidiaries - SteriLumen, Inc.

("SteriLumen") and Munn Works, LLC ("Munn Works"). SteriLumen's connected

platform for Data Driven Disinfection(tm) applies the power of ultraviolet light (UVC)

to destroy pathogens safely, thoroughly, and automatically, addressing the

challenge of healthcare-acquired infections ("HAIs"). Targeted for use in facilities

that have high customer turnover such as hospitals, hotels, commercial facilities,

and other public spaces, the Company's Lumicide(tm) platform uses UVC LEDs in

several patented designs for infection control in and around high-traffic areas,

including sinks and restrooms, killing bacteria, viruses, and other pathogens

residing on hard surfaces within devices' proximity. The Company's patented in-

drain disinfection device, Lumicide Drain, is the only product on the market that

addresses this critical pathogen intensive location. SteriLumen's Airocide(r) air

purification devices are research backed, clinically proven and developed for NASA

with assistance from the University of Wisconsin. Airocide(r) is listed as an FDA

Class II Medical device, utilizes a proprietary photocatalytic (PCO) bioconversion

technology that draws air into a reaction chamber that converts damaging molds,

microorganisms, dangerous airborne pathogens, destructive VOCs, allergens, odors

and biological gasses into harmless water vapor and green carbon dioxide without

producing ozone or other harmful byproducts. Airocide(r) applications include

healthcare, hospitality, grocery chains, wine making facilities, commercial real

estate, schools, dental offices, post-harvest, grocery, cannabis facilities and homes.

For more information about Applied UV, Inc., and its subsidiaries, please visit the

following websites: https://www.applieduvinc.com/; https://sterilumen.com/;

https://www.airocide.com https://kesscience.com;

https://scientificairmanagement.com and, https://munnworks.com/.

Forward-Looking Statements

The information contained herein may contain "forwardlooking statements."

Forwardlooking statements reflect the current view about future events. When

used in this press release, the words "anticipate," "believe," "estimate," "expect,"

"future," "intend," "plan," or the negative of these terms and similar expressions,

as they relate to us or our management, identify forwardlooking statements. Such

statements include, but are not limited to, statements contained in this press

release relating to the view of management of Applied UV concerning its business

strategy, future operating results and liquidity and capital resources outlook.

Forwardlooking statements are based on the Company's current expectations

and assumptions regarding its business, the economy and other future

conditions. Because forward--looking statements relate to the future, they

are subject to inherent uncertainties, risks and changes in circumstances

that are difficult to predict. The Company's actual results may differ

materially from those contemplated by the forwardlooking statements. They

are neither statements of historical fact nor guarantees of assurance of future

performance. We caution you therefore against relying on any of these forward

looking statements. Factors or events that could cause the Company's actual

results to differ may emerge from time to time, and it is not possible for the

Company to predict all of them. The Company cannot guarantee future results,

levels of activity, performance, or achievements. Except as required by applicable

law, including the securities laws of the United States, the Company does not intend

to update any of the forwardlooking statements to conform these statements to

actual results.